You are here

Docket Number 3586

Received: 
Monday, December 20, 2021
Commodity: 
Monomer-Dimer Hybrid Immunoconjugates
Investigation Number: 
Withdrawn
Filed By: 
Scott K. Reed
Firm/Organization: 
Venable LLP
Behalf Of: 
Bioverativ Therapeutics Inc., Genzyme Corporation, Genzyme Europe B.V., Bioverativ U.S. LLC, and Bioverativ Pacific LLC
Confidential: 
Yes
Country: 
None
Description: 
Letter to Lisa R. Barton, Secretary, USITC; requesting that the Commission conduct an investigation under section 337 of the Tariff Act of 1930, as amended, in the matter of certain monomer-dimer hybrid immunoconjugates. The proposed respondents are Hanmi Pharmaceutical Co., Ltd., Korea; and Spectrum Pharmaceuticals, Inc., Henderson, NV.
Petition/Complaint Status: 
Withdrawn